Jin Medical International Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Cash & Equivalents	11.13	8.14	6.93	4.79	3.67	1.66
Short-Term Investments	19.82	18.62	9.77	2.28	2.05	1.18
Cash & Short-Term Investments	30.96	26.76	16.7	7.07	5.73	2.84
Cash Growth	19.12%	60.24%	136.23%	23.43%	101.69%	-15.06%
Accounts Receivable	5.62	8.46	4.23	4.08	4.86	7.46
Other Receivables	0.51	0.32	0.08	0.17	1.11	0.22
Receivables	6.13	8.78	4.31	4.25	5.98	7.68
Inventory	6.1	7.12	5.86	6.88	7.04	7.25
Prepaid Expenses	0.09	0.17	0.06	-	-	-
Other Current Assets	0.51	-	4.19	0.7	0.67	0.39
Total Current Assets	43.78	42.82	31.12	18.9	19.42	18.16
Property, Plant & Equipment	3.51	1.72	1.48	1.63	2.11	2.31
Other Intangible Assets	1.09	1.15	0.15	0.16	0.19	0.18
Long-Term Deferred Tax Assets	0.13	0.12	0.15	0.25	0.18	0.17
Total Assets	48.52	45.8	32.9	20.94	21.9	20.82
Accounts Payable	3.06	3.01	3.39	4.11	5.35	5.43
Accrued Expenses	0.45	0.75	0.33	0.47	0.74	0.77
Short-Term Debt	15.73	11.32	4.11	-	-	2.65
Current Portion of Leases	0.16	0.19	-	-	-	-
Current Income Taxes Payable	0.61	0.81	0.26	0.17	0.1	0.08
Current Unearned Revenue	0.46	0.8	0.83	0.83	1.68	0.98
Other Current Liabilities	0.28	0.28	0	0.12	0.01	0.11
Total Current Liabilities	20.74	17.15	8.92	5.7	7.87	10.01
Long-Term Leases	0.03	0.1	-	-	-	-
Total Liabilities	20.77	17.25	8.92	5.7	7.87	10.01
Common Stock	0.01	0.01	0.01	0.01	0.01	0.02
Additional Paid-In Capital	6.75	6.75	6.44	0.08	0.08	0.07
Retained Earnings	22.53	22.61	18.94	16.06	13.35	10.72
Comprehensive Income & Other	-1.37	-0.56	-1.4	-0.91	0.59	-0.01
Total Common Equity	27.91	28.82	23.98	15.24	14.03	10.8
Minority Interest	-0.16	-0.26	-	-	-	-
Shareholders' Equity	27.76	28.55	23.98	15.24	14.03	10.8
Total Liabilities & Equity	48.52	45.8	32.9	20.94	21.9	20.82
Total Debt	15.92	11.6	4.11	-	-	2.65
Net Cash (Debt)	15.04	15.15	12.59	7.07	5.73	0.19
Net Cash Growth	-6.22%	20.41%	78.04%	23.43%	2879.90%	-59.20%
Net Cash Per Share	0.10	0.10	0.09	0.05	0.04	0.00
Filing Date Shares Outstanding	156.55	156.55	156.55	135	400	400
Total Common Shares Outstanding	156.55	156.55	155.95	135	400	400
Working Capital	23.04	25.66	22.19	13.2	11.55	8.14
Book Value Per Share	0.18	0.18	0.15	0.11	0.04	0.03
Tangible Book Value	26.82	27.67	23.82	15.07	13.84	10.62
Tangible Book Value Per Share	0.17	0.18	0.15	0.11	0.03	0.03
Buildings	2.41	2.49	2.4	2.46	2.71	2.57
Machinery	2.65	2.74	2.56	2.54	2.76	2.62
Construction In Progress	2.04	-	-	-	-	-
Leasehold Improvements	0.35	0.36	0.28	0.29	0.32	0.3

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q